EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000025002
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024977
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024865
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024959
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000000403
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000016843
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000016817
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000016799
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000016782
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024898
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000027367
Gene Symbol: TAAR1
1 Cross references
330 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSLBEG00000002621
Gene Symbol: LOC109993466
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).